Antigen-adjuvant combination could induce a protective and long-lasting anti-tumor immune
response. However, exploiting system which could co-deliver melanoma antigen peptide …

Tumor vaccine has brought a new dawn for cancer immunotherapy, but disillusionary
therapeutic outcomes have been achieved due to the inefficient in vivo vaccine delivery …

Toll-like receptors (TLRs) are a class of pattern recognition receptors (PRRs) crucial for the
detection of infections and activation of downstream signaling pathways that lead to the …

Melanoma accounts for the highest proportion of all skin cancer deaths. Immune-
chemotherapy has transformed anti-melanoma therapy and is a preferred first-line …

Immunotherapy aiming to harness the exquisite power of the immune system has emerged
as a crucial part of clinical cancer management. However, only a subset of cancer patients …

Chemo-immunotherapy has gained increasing attention as one of the most promising
combination therapy strategies to battle cancer. In this study, the therapeutic nanoparticles …

Cancer vaccine contributing to the success of the treatment and prevention of tumors has
attracted a huge attention as a strategy for tumor immunotherapy in recent years. A major …

Cancer immunotherapy is the most promising method for tumor therapy in recent years,
among which the macrophages play a critical role in the antitumor immune response …

Cancer vaccines for prevention and treatment of tumors have attracted tremendous interests
as a type of cancer immunotherapy strategy. A major challenge in achieving robust T-cell …

High-efficiency treatment for tumor is not easy to achieve owing to the existence of
metastasis, which remains the arch-criminal of most tumor deaths. Conventional …